Director, Biostatistics, Early Phase
Revolution Medicines - Redwood City, California, United States
Posted Aug 15, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $211K-$264K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Market context
- U.S. role benchmark (BLS OEWS)
- $111,944 U.S. median for this role
- Projected growth (BLS Employment Projections)
- +13.7% - Much faster than average
112% above the BLS role benchmark for data and ml aggregate.
Matched to SOC 15-1252 - Data and ML aggregate by role bucket.
Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.
Role
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Biostatistics, Early Phase Redwood City, California, United States Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: This position is to serve as lead statistician for oncology studies, and to coordinate activities with other functional groups to ensure timely deliverables. - Represent biostatistics on study/project teams. - Provide statistical expertise for design, analysis and reporting of clinical studies. - Collaborate with various functions on study design and planning, protocol development, statistical methodology and analysis. - Develop statistical analysis plans and analysis specifications. - Collaborate with statistical programming to ensure that analysis is conducted per statistical plan and specifications. - Collaborate with data management and clinical operations to ensure robust database development and quality data collection. - Provide statistical input to regulatory interaction and response to health authority submissions. - Collaborate in publications, assist in data interpretation, and ensure consistency and accuracy in data presentation. - Contribute to
Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Director, Biostatistics, Late Clinical Stage
Revolution Medicines - Redwood City, California, United States
Director, Biostatistics
Tango Therapeutics Inc - Boston, MA
Director, Biostatistics
Syndax Pharmaceuticals Inc - New York, NY
Senior Director, Biostatistics
Cytokinetics Inc - South San Francisco, California